We work only with long-established manufacturing partners and maintain clear documentation for every peptide we supply
REDEFINE-4 reported about 25.5% at 84 weeks in a head-to-head trial
Unlike many compounds marketed as anti-aging therapies, GHK-Cu is not merely a cosmetic molecule
doi:10.1093/brain/awh287 95. Pia, H., Ruzena, K., Andrzej, P., Abdonas, T., Ben, S., Hynek, P., Anne, P., Magdalena, K., Eufene, J., Archana, S.-M., & Martin, B
To obtain additional restraints for structural model determination of the p53 TAD2 -FOXO4 FH complex, we determined paramagnetic relaxation enhancements (PREs) for a set of 7 complexes containing spin-labeled (SL) samples ( 15 N-labeled FOXO4 FH + S46C-SL p53 TAD2 , 15 N-labeled FOXO4 FH + Q52C-SL p53 TAD2 , 15 N-labeled p53 TAD2 + Q112C-SL FOXO4 FH , 15 N-labeled p53 TAD2 + D140C-SL FOXO4 FH , 15 N-labeled p53 TAD2 + N145C-SL FOXO4 FH , 15 N-labeled p53 TAD2 + S159C-SL FOXO4 FH , 15 N-labeled p53 TAD2 + S162C-SL FOXO4 FH )
doi: 10.1023/a:1008211226339